FDA Grants Priority Review To Insmed's SNDA For Arikayce For Treatment Of Mac Lung Disease With PDUFA Target Action Date Set For January 28, 2027

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.